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Iron and the Liver: Acute Effects of Iron-loading
Hepatic Heme Synthesis of Rats

on

ROLE OF DECREASED ACTIVITY OF
5-AMINOLEVULINATE DEHYDRASE
HERBERT L. BONKOWSKY, JOHN F. HEALEY, PETER R. SINCLAIR,
JACQUELINE F. SINCLAIR, STEVEN I. SHEDLOFSKY, and GEORGE H. ELDER,
Hepatology/Metabolism Laboratory, Veterans Administration Medical
Center, White River Junction, Vermont 05001; Departments of Medicine and
Biochemistry, Dartmouth Medical School, Hanover, New Hampshire 03755;
Department of Medical Biochemistry, Welsh National School of Medicine,
Cardiff, Wales

A B S T R A C T Acute iron loading of rats, by intraperitoneal administration of iron-dextran (500 mg Fe/kg
body wt 18-20 h before killing) decreased by 30% the
rate of conversion of 5-amino-['4Cllevulinate (['4C]ALA)
into heme as measured with a recently described procedure for liver homogenates (1981. Biochem. J. 198:
595-604). The decrease in conversion of labeled ALA
into heme caused by iron loading was shown to be due
to a 70-80% decrease in activity of ALA dehydrase.
The decrease in activity of ALA dehydrase caused by
iron loading was not associated with a decrease in hepatic concentrations of GSH, nor could it be reversed
by addition of dithiothreitol, Zn2+ or chelators of Fe2+
and Fe3'. Addition of FeSO4, ferric citrate, or ferritin
to homogenates of control liver had no effect of activity
of ALA dehydrase. The decrease in activity of ALA
dehydrase, caused by iron-dextran, was mirrored by
a reciprocal increase in ALA synthase. Iron-dextran
potentiated the induction of ALA synthase by allylisopropylacetamide. However, this potentiation could
be dissociated from the decrease in ALA dehydrase
caused by iron loading.
INTRODUCTION
After administration of a single dose of iron-dextran
to rats, there is a transient increase in activity of heA portion of this work has appeared in abstract form in

1981. Hepatology. 1: 497.
Address reprint requests to Dr. Bonkowsky, Veterans Administration Medical Center.

patic 5-aminolevulinate (ALA)' synthase, the rate-limiting enzyme in hepatic heme biosynthesis (1). The
peak of the increase (four- to sixfold above control)
occurs 12-24 h after treatment; by 48 h the activity
of ALA synthase decreases to 1.5-fold greater than
control, and persists for several weeks (1, 2).
According to current concepts, a regulatory heme
pool exerts endproduct negative feedback control on
synthesis of ALA synthase (for recent reviews, see refs.
3-5). Decreases in this heme pool may arise as the
result of enhanced heme breakdown or of decreased
heme synthesis. It has been proposed by some investigators that iron decreases hepatic heme synthesis by
inhibiting uroporphyrinogen decarboxylase (6). However, others have reported no effect (7) or activation
(8) of the decarboxylase by ionic iron. We have also
failed to find evidence for a decrease in activity of
uroporphyrinogen decarboxylase in iron-loaded liver

(1, 9).

In this paper, we use a procedure recently developed
by our laboratory (10) to show that the rate of heme
synthesis from ALA is diminished in liver homogenates
of iron-loaded rats. We further show that the decrease
can be-accounted for by a decrease in activity of ALAdehydrase that occurs in iron-loaded livers.
' Abbreviations used in this paper: AIA, allylisopropylacetamide; ALA, 5-aminolevulinate; ['4C]ALA, 5-amino-[4'4C]levulinic acid; BHT, butylated hydroxytoluene; DTT,
dithiothreitol; PBG, porphobilinogen.
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METHODS
Animals and preparation of liver homogenates. Male
Sprague-Dawley rats (150-200 g) were kept as previously
described (11) and starved 24 h before killing. Rats treated
with iron-dextran >24 h before killing were starved 16 h
before injection with iron-dextran, refed after injection, and
starved again 24 h before killing. All controls received dextran-5 (2 g/kg) in normal saline (200 mg/ml). Both irondextran and dextran-5 were tolerated well as reported previously (1).
Rats were killed by decapitation and their livers quickly
removed, weighed, and homogenized (20% wt/vol) in icecold 0.25 M sucrose/0.02 M Tris/HCl (pH 7.4). Where indicated, these 20% homogenates were frozen (-60'C) before
use for measurements other than ALA synthase. In most experiments, we immediately added the antioxidant, butylated
hydroxytoluene (BHT) (90 gM final), to homogenates with
thorough mixing. For studies that included a determination
of ALA synthase activity, we took a separate piece of the
liver and homogenized it in a different buffer (see next section). We homogenized livers 15-20 s with a Polytron homogenizer (Brinkmann Instruments, Westbury, NY) at low
speed and, just before use, diluted homogenates to 7.7% wt/
vol, with sucrose/Tris buffer.
Assay procedures. Activities of ALA synthase and concentrations of hepatic GSH and iron were measured as previously described (1). The conversion of ['4C]ALA into heme
and heme precursors, and the extraction of unconjugated
bilirubin were performed as described earlier (10). We measured malondialdehyde (MDA) by the method of Buege and
Aust (12).
Activities of ALA dehydrase were routinely measured in
7.7% (wt/vol) homogenates containing ALA (5 mM), dithiothreitol (DTT) (10 mM), and BHT (45 uM). DTT was
sometimes omitted, as described in Results. Tubes containing
a total volume of 0.65 ml were incubated for 30 min at 370C
in a shaking water bath. We stopped the reaction by placing
the tubes in a slurry of water and ice and added 2 vol of
7.5% TCA:0.05 M HgCl2 with mixing. After centrifugation
(1,000 g, 10 minm) we mixed 1 ml of supernatant with 1 ml
modified Ehrlich's reagent (13), and after 15-25 min,
scanned the mixture from 500-680 nm against a "blank"
using an Aminco DW2 Spectrophotometer (American Instrument Co., Silver Springs, MD). The "blank" consisted
of homogenate to which TCA had been added at zero time
and that had been kept on ice for 30 min. We calculated
porphobilinogen concentrations using a A/(555-650 nm) of
61,000 (13).
Activities of uroporphyrinogen decarboxylase were measured in 20% (wt/vol) homogenates by determining the rate
of decarboxylation of pentacarboxylate porphyrinogen III
to coproporphyrinogen III (14).
Use of BHT as antioxidant. In previous studies, FeSO4,
in the presence of the antioxidant menadione, increased the
rate of formation of heme from ALA by homogenates of rat
liver, although menadione alone decreased the rate of conversion of ALA into heme (10). We now find the antioxidant,
BI-T, is also effective in preventing iron-stimulated lipid
peroxidation, as assayed by accumulation of MDA. Furthermore, unlike menadione, BHT alone does not decrease
accumulation of labeled heme from ['4C]ALA. Therefore, we
used BHT routinely in the present studies.
Reagents. Unless otherwise noted, chemicals were dissolved just prior to use in the sucrose/Tris buffer, pH 7.4.
4,6-Dioxoheptanoic acid, and ferritin (Cd-free from horse
spleen) were from United States Biochemical Corp. (Cleve-
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land, OH). BHT (Aldrich Chemical Co., Milwaukee, WI)
was dissolved in ethanol (10 mg/ml). Allylisopropylacetamide (AIA) (15 mg/ml), a gift from Hoffmann-LaRoche
(Nutley, NJ), was dissolved in hot 0.15 M NaCl. After the
solution had cooled, it was administered subeutaneously in
a dose of 400 mg/kg body wt. Controls received saline. [414C]ALA (51.5. mCi/mmol) was purchased from New England
Nuclear (Boston, MA) and prepared as described previously (10).
Unlabeled ALA (Sigma Chemical Co., St. Louis, MO) was
dissolved in 0.1 M sodium phosphate buffer and titrated to pH
7.0. Menadione and ferrozine were from Sigma Chemical Co.
We dissolved zinc sulfate (Sigma Chemical Co.) in distilled
water, and ferrous sulfate (ACS grade, Fisher Scientific Co.,
Pittsburgh, PA) in 1 mM HCI. 2-Thiobarbituric acid was from
Sigma; desferrioxamine mesylate (Desferal) was from CIBAGeigy (Summit, NJ). Dextran-5 was dissolved in normal saline
(200 mg/ml final concentration). Iron-dextran and dextran-5
were gifts from Fisons, Ltd. (Holmes Chapel, Cheshire, England). Pentacarboxylic porphyrin III and mesoporphyrin IX
were gifts from Professor A. H. Jackson, University College,
Cardiff, England.
RESULTS

Conversion of ['4C]ALA into heme and
porphyrins by iron-loaded liver
As shown in Table I, liver homogenates of rats
treated with iron-dextran 20 h before killing, when
incubated with ["4C]ALA, accumulated significantly
less radioactivity in protoporphyrin and heme than did
controls. There are three possible explanations for this
difference. In homogenates of iron-loaded rats, compared to controls, there may be: (a) increased breakdown of labeled heme; (b) greater dilution of the added
['4C]ALA by endogenous ALA; or (c) decreased rates
of synthesis of heme or heme precursors.
Does decreased heme radioactivity occur due to
breakdown of labeled heme during incubation of liver
homogenates? Fig. 1 shows that heme was stable in
vitro for 30-90 min in homogenates of control and
iron-loaded liver with BHT. A decrease in radioactivity in heme with time occurred in homogenates of
iron-loaded liver only when BHT was omitted. In other
studies in which higher concentrations of ALA were
used, we assumed heme was also stable, as in Fig. 1.
Is the decreased heme radioactivity due to dilution

of [14C]ALA by endogenous ALA? Administration of
iron-dextran to rats is known to increase hepatic ALA
synthase (1, 15, see Fig. 2). An increase in this enzyme
could increase the endogenous hepatic pool of ALA
sufficiently to dilute exogenously added [14C]ALA and
thereby decrease the accumulation of radioactivity in
heme and protoporphyrin. To determine the contribution of endogenous ALA, we incubated homogenates with two different concentrations of unlabeled
ALA keeping the amount of labeled ALA constant.
Table II shows the results of a typical experiment,
performed with homogenates of iron-loaded livers that
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TABLE I

Decreased Accumulation of Radioactivity in Heme and Protoporphyrin by Liver
Homogenates of Iron-loaded Rats Incubated with ['4C]ALA
M[protoporphyrin
Treatment of rats

n

Heme

Protoporphyrin

+ heme]

dpM X 10-3

Control
Iron loaded

3
4

84.3±6.2
56.4±8.3*

11.5±0.7
4.0±0.9"

95.8±6.0
60.4±7.8°

Iron-loaded rats received iron-dextran, 500 mg Fe/kg body wt, in a single i.p. injection
20 h before killing. Control rats received an appropriate amount of dextran-5 i.p. Incubations (30 min) of 0.65 ml of 7.7% wt/vol homogenates of individual livers were
carried out as described (10), in the presence of 45 MM BHT, 0.2 MCi of [14CIALA and
a final ALA concentration of 22 uM. Protoporphyrin was the only porphyrin that accumulated to a measurable extent (10). Differences between mean values were compared
using the students two-tailed t test.
° Significantly different from control (P < 0.005).

had a 5.7-fold increase in ALA synthase. The observed
ratios of b/a in the table provide a means for estimating the endogenous pools of ALA. The endogenous
pool of ALA is slightly higher in homogenates of ironloaded than of control livers. However, the increase
(0.8 nmol/50 mg liver), calculated from the observed
ratios, is small relative to the amount of exogenous
ALA (26 nmol) routinely used in homogenate incubation. Thus, dilution of ['4C]ALA by endogenous ALA
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FIGURE 2 Effects of iron loading on hepatic ALA synthase,
ALA dehydrase, GSH, and total iron. Rats, treated as described in Methods, were killed at various times after injection. Assays of ALA dehydrase, GSH, and Fe were performed
on homogenates of individual livers; n = 3-5 for both controls and iron-loaded animals, except for assays of liver iron
in control rats that were performed on portions of single
livers. Assays of ALA synthase in homogenates of iron-loaded
livers were performed on two separate pools of liver containing two to three livers per pool, except for the 24-h time
point, which was done on a single pool of three livers. For
ALA dehydrase, GSH and Fe, results are mean±1 SD; for
ALA synthase, the values for each pool are presented. Open
symbols, control; closed symbols, iron-loaded.
-

Minutes of incubation

FIGURE 1

Stability of labeled heme synthesized from

[I4C]ALA by homogenates of control and iron-loaded

livers.

Freshly prepared homogenates of liver (15.4% wt/vol), from
rats treated as described in the legend to Table I and killed
24 h after treatment, were incubated with 0.1 MCi (1.9 nmol)
['4C]ALA. Total volume of incubation was 0.65 ml. In these
studies, an additional extraction step was carried out to remove any bilirubin that might otherwise have remained in
the heme fraction (10). The concentration of BHT was 70
AM. The recovery of labeled heme was 74% (10).

Iron Loading and Hepatic Heme Synthesis

1177

TABLE II
Effect of Changing the Concentration of Exogenous Carrier ALA on Incorporation
of ['4CJALA into Heme by Homogenates of Rat Liver
a

b

b/a

b/a

21.8 #M ALA

43.6 pM ALA

Observed

assuming no
dilution

Theoretical,
Type of
homogenate

n

Radioactivity in heme

[dpm X

Control
Iron loaded

3
4

116.0±4.5
68.7±11.0

101-

63.2±2.6
39.6±5.7

0.546±0.004

0.577±0.013°

0.500
0.500

Rats were injected intraperitoneally with dextran-5 (control) or iron-dextran (ironloaded) and killed 18 h later. Homogenates (7.7% wt/vol) of liver were incubated, in
the presence of FeSO4 (0.25 mM) and BHT (45 WM), with two preparations of ALA,
a and b, both of which contained the same amount of ['4C]ALA (0.2 MCi). However,
preparation b contained twice the total amount of ALA as did a. The extent to which
the observed ratios of radioactivity in herne (column 3) differ from the theoretical,
assuming no dilution of added ALA by endogenous ALA (column 4), provides an estimate
of the relative sizes of the endogenous pools. Results are mean±SD. In the homogenates
used, activities of ALA synthase were: control, 30 nmol ALA/g- h; iron-loaded, 171
nmol ALA/g h; and activities of ALA dehydrase were: control, 2060 nmol PBG/gh; iron-loaded, 559 nmol PBG/g * h.
° Significantly greater than control value (P = 0.011).

could only contribute a small fraction of the change
observed.
Is decreased heme radioactivity due to a decreased
rate of synthesis of heme or heme precursors? The
elimination of (a) and (b) coupled together with data
of Table I imply there is a decreased rate of synthesis
of labeled heme and heme precursors from ['4C]ALA
in homogenates of iron-loaded rats. Previously, it had
been found that administration of ferric citrate (16)
or iron-dextran (17) to rats decreased activity of ALA
dehydrase. Therefore, we made further studies of the
effect of iron-loading on this enzyme, particularly on
the time sequence and on heme synthesis in vitro.

Effect of iron loading on hepatic
ALA dehydrase
Iron loading produced a marked decrease in activity
of ALA dehydrase that was mirrored by a reciprocal
increase in ALA synthase (Fig. 2a). A transient decrease in activity of ALA dehydrase was observed after
iron loading, in five separate experiments, although
there was some variability in the maximal degree of
the decrease (50-80%) and the time after iron treatment at which the nadir occurred (12-20 h).
Kinetics of ALA dehydrase in iron-loaded livers.
The major effect of iron loading on ALA-dehydrase
was to decrease the maximum velocity (Vmax) (At 18
h, control = 1,600 nmol porphobilinogen (PBG)/g
liver/h; iron-loaded = 394 nmol PBG/g liver per h).
1178

The extent of the decrease depended on the time of
iron treatment. The Michaelis constant (KM) of the
enzyme was approximately the same for control and
iron-loaded livers (control = 105 AtM; iron-loaded = 91

AM ALA).

The following may be responsible for the decrease
in activity of ALA dehydrase: (a) effects on sulfhydryl
groups, (b) a deficiency of zinc, (c) direct inactivation
of enzyme by iron, (d) lipid peroxidation, and (e) accumulation of a soluble inhibitor of the enzyme. (a)
ALA dehydrase is well known to require sulfhydryl
groups for activity (18); two observations indicate that
the decrease we observed is not due to depletion of
hepatic thiols. First, hepatic concentrations of GSH
were not decreased by iron treatment in vivo (Fig. 2b).
Second, omission of DTT from the assay for ALA dehydrase produced only a 10-15% decrease in activity
in homogenates of both control and iron-loaded livers.
(b) ALA dehydrase also requires Zn21 for activity (18);
thus we tested the effect of the addition of Zn21 (0.11.0 mM) with or without 20 min of preincubation, on
activity of the enzyme in homogenates of iron-loaded
liver. When added to liver homogenates from control
rats or from rats treated with iron-dextran, Zn2+ either
had no effect (at 0.1 mM) or decreased activity by 50%
(at 0.5 mM) or 80% (at 1.0 mM). (c) Another possibility
is that some iron compound inhibits ALA dehydrase
directly. We investigated this possibility in rat liver
homogenates in vitro, by adding either different iron
compounds to control homogenates or chelators of iron
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to homogenates from rats treated with iron dextran.
FeSO4, iron-dextran, ferric citrate or ferritin (each at
0.25, 1.5, and 5 mM Fe) had no appreciable effect on
activity of the dehydrase in homogenates of control
rat liver. (The concentration of iron in 10% homogenate of iron-loaded liver 18-24 h after treatment is
-1 mNI). When liver homogenates from rats treated
with iron-dextran 12 or 18 h before killing were treated
with desferrioxamine (7 mnM), a chelator of Fe"+ (19),
ferrozine (0.25 mM), a chelator of Fe 2 (20), or a combination of the two, there was no increase in activity
of ALA dehydrase. At these or lower concentrations,
the chelators alone did not affect activity of ALA dehydrase in homogenates of control livers. (Concentrations of ferrozine >0.25 mM decreased activity of dehydrase in homogenates of control livers.) (d) The decrease in dehydrase activity in homogenates of ironloaded livers could not be attributed to iron-catalyzed
lipid peroxidation in vitro since addition of BHT to
the assay, which totally prevented formation of malonaldehyde, had no effect upon dehydrase activity.
Also, the addition of iron salts, with or without BHT,
to homogenates of control liver had no effect on activity of ALA dehydrase, regardless of iron-catalyzed
lipid peroxidation. (e) Equal volumes of homogenates
of control and iron-loaded livers were mixed together.
The activity of ALA dehydrase was the theoretical
additive amount expected from each component of the
mixture. Such an experiment provided no evidence for
a soluble inhibitor in iron-loaded livers.

Effect of decreased activity of ALA
dehydrase on conversion of ["4C]ALA to
heme and protoporphyrin by ironloaded livers
We next asked to what extent the decrease in activity
of ALA dehydrase would decrease the conversion of
ALA to protoporphyrin and heme. With increasing
concentrations of 4,6-dioxoheptanoic acid, a potent
inhibitor of ALA dehydrase (21), the dehydrase was
decreased to different extents and the resulting decrease in accumulation of radioactivity into 2(protoporphyrin and heme) from ['4C]ALA is shown in Fig.
3. The percent decrease in ALA dehydrase was always
much greater than the decrease in accumulation of
radioactivity. As shown in Fig. 3, the various decreases
in dehydrase activity caused by iron loading led to
decreases in accumulation of radioactivity identical to
those caused by 4,6-dioxoheptanoic acid. The curves
obtained were superimposable and show that the decreased accumulation of radioactivity into 2(protoporphyrin and heme) in the homogenates of the ironloaded liver can be explained solely by the decrease
in ALA dehydrase.

0
80
40
60
20
100
Percent decrease in activity of ALA dehydrase

FIGURE 3 Similar effects of two ways of decreasing activity
of ALA dehvdrase upon conversion of ALA to 2[protoporphyrin + heme] by liver homogenates. Activity of ALA dehydrase was decreased by (a) injecting rats with iron-dextran, 500 mg Fe/kg, at various times (4-48 h) before killing,
or (b) adding increasing concentrations (shown in parentheses) of 4,6-dioxoheptanoic acid to homogenate of normal
liver. Assays for ALA defivdrase and conversion of [14C]ALA
to 1[protoporphyrin + heme] were as described in Methods.
Each point is the result for a single rat given iron-dextran;
results of three separate experiments are summarized toX gives results for homogenates to which 4,6gether. X
dioxoheptanoic acid was added 5 min before assay.

The kinetics of the incorporation of ALA into
2(protoporphyrin + heme) were determined using homogenates of control and iron-loaded livers. The activity of ALA dehydrase in the homogenate of the ironloaded liver was decreased by 75%. The concentration
of ALA needed to achieve half-maximal rates of formation of 2(protoporphyrin + heme) was increased
from 5 ,uM (control) to 9 FM (iron-loaded).
The inhibition of l(protoporphyrin + heme) in Fig.
3 was obtained using an initial concentration of 40
,M ALA and 30-min incubations. Decreasing the initial concentration of ALA to 5 ,M increased the inhibition of heme synthesis, whereas increasing the initial concentration of ALA to 100 FM decreased the
inhibition (Table 1II). Also, the inhibition of heme formation was greater for all concentrations of ALA when
the incubations were stopped at 5 min. These results
indicate that there is a lag in the production of labeled
heme, which probably is due to lag in PBG synthesis.
We next looked for evidence of inhibition of other
steps of the pathway between ALA and heme. Homogenates of control and iron-loaded liver were incubated for 1 h with a high concentration of unlabeled
ALA (1 mM), and the amount and type of porphyrins
that accumulated were measured. In this study, we
Iron Loading and Hepatic Heme Synthesis
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TABLE III
Effect of Different Initial Concentrations of [14C]ALA on Initial
Rates of 14C-Ileme Synthesis by Homogenate
of Iron-loaded vs. Control Livers

-j

AIA + Iron

600k

E

4001

Initial concentration of ALA, AuM
5

a. ALA synthase

800

AlA

100

40

200
Duration of
incubation

Ratio of the rate of labeled heme formation,
iron-loaded/control

Iron _-

-J

X

ccI

5

10

15

96

20

min

5
10
15

0.30
0.41

0.43

0.42
0.50
0.52

0.47
0.55
0.55

-

m

a_

1500

75

Homogenates from rats described in Fig. 4 were incubated in the
presence of FeSO4 (0.25 mM) and BHT (45 MAM) with three concentrations of [14C]ALA. Heme was extracted from the samples and
counted as described in Methods. For ease of comparison, the accumulation of label in heme by homogenate of iron-loaded liver
is presented as a fraction of that by homogenate of control liver.

b. ALA dehydrase

2000

f

koal

Contr_

a

1

E
u

1000

O

500

1[

-i

5

10

15

20

96

Hours after first treatment

added FeSO4 (0.25 mM) to control homogenate to pro- FIGURE 4 Effect of administration of iron-dextran and AIA
ALA synthase and ALA dehydrase. Rats were
vide optimal substrate for ferrochelatase (10). Addition on hepatic
for 12 h before their first treatment. Rats killed 4 or
of FeSO4 to iron-loaded homogenate did not enhance starved
18 h after treatment (first and second time points) were given
accumulation of labeled heme. Both kinds of homog- iron-dextran i.p. (500 mg Fe/kg), AIA s.c. (400 mg/kg), or
enate accumulated similar amounts of porphyrin, 0.8 the combination, and starvation was continued until killing.
nmol/g of uro- plus coproporphyrin, and 2.0 nmol/g Rats killed 96 h after first treatment (third time point) were
given iron-dextran, after which they were refed for 66
of protoporphyrin. Thus, iron loading does not cause first
h. Then food was again withheld until killing, and some were
accumulation of heme precursors in the biosynthetic given AIA 18 h before killing. Control rats received appropathway leading to protoporphyrin. Furthermore, priate amounts of dextran-5 and normal saline in place of
treatment of rats with iron-dextran had no effect on iron-dextran and AIA, respectively. ALA synthase was meaon pooled homogenates of two or three separate livers.
activity of hepatic uroporphyrinogen decarboxylase, sured
point is the value for a single pool. ALA dehydrase was
measured 4 and 18 h after treatment (results not Each
measured on homogenates of individual livers. Each point
shown).
is the mean±SD of three to six livers.

Effect of iron-dextran, AIA, and the
combination on activities of hepatic
ALA synthase, ALA dehydrase, and
uroporphyrinogen decarboxylase
Administration of ferric citrate (9, 16) or iron-dextran (1) to rats potentiates the induction of hepatic
ALA synthase produced by the porphyrogenic chemical AIA. To test whether this potentiation by iron is
related to a decrease in activity of ALA dehydrase, or
uroporphyrinogen decarboxylase, we performed experiments of the type summarized in Fig. 4. AIA, given
simultaneously with iron-dextran, prevented the decrease in activity of ALA dehydrase produced by irondextran alone (Fig. 4b, 18 h time point). AIA treatment, with or without iron-dextran, did not affect hepatic uroporphyrinogen decarboxylase measured 4 and
18 h after treatment (results not shown). Thus, iron-
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mediated potentiation of AIA induction of ALA-synthase occurred despite no decrease in the activities of
ALA-dehydrase or uroporphyrinogen decarboxylase.
DISCUSSION
In this paper we have presented new evidence for effects of iron on enzymes of the heme biosynthetic pathway. We have observed transient effects of a single
iron dose, namely, a decrease in ALA dehydrase and
a reciprocal mirrored increase in ALA synthase (Fig.
2a). The effect of the iron loading on heme synthesis
in vivo was estimated by studying the ability of homogenates of the livers to convert ['4C]ALA to heme
and protoporphyrin. The rate of the conversion was
decreased in liver homogenates from animals 18-20
h after being loaded with iron, even when the homogenates were incubated in the presence of the anti-

Bonkowsky, Healey, Sinclair, Sinclair, Shedlofsky, and Elder

oxidant, BHT, which suppresses lipid peroxidation
(Table I). We concluded the decreased heme synthesis
could be attributed solely to the decreased activity of
ALA dehydrase for the following reasons: (a) Decreased heme synthesis was not due to dilution of
added ["4C]ALA by an expanded endogenous pool
(Table II) nor by increased breakdown of heme (Fig.
1); (b) No increase or decrease in accumulation of porphyrins was observed when homogenates of ironloaded livers were incubated with excess ALA. These
results are consistent with there being no decrease in
PBG deaminase as reported by others (17), nor decrease in later enzymes of the pathway. Furthermore,
using a method (14) other than used previously (9, 22),
we still failed to detect any decrease in uroporphyrinogen decarboxylase in iron-loaded liver homogenates;
(c) Decreases in ALA dehydrase, either by iron-loading
in vivo or by adding 4,6-dioxoheptanoic acid, caused
identical decreases in conversion of [14C]ALA to heme
by homogenates (Fig. 3).
The cause of the transient decrease in activity of
ALA dehydrase mediated in vivo by iron treatment
remains unknown. We could find no evidence that it
was due (a) to direct action of either some iron compound or other soluble inhibitor; (b) to iron-catalyzed
lipid peroxidation in vitro; (c) to depletion of GSH in
vivo; or (d) to a deficiency of zinc. Our inability to
inhibit ALA dehydrase in vitro with ferric citrate differs from previous findings (16) possibly because of the
different assay methods used.
The decrease in activity of ALA dehydrase caused
by iron loading was rapid and transient (Fig. 2a). If
the half-life of the dehydrase molecules in normal rat
liver is similar to the half-life of the mouse liver enzyme (5-6 d) (23), our results imply either that acute
iron loading increases the catabolism of the dehydrase
molecules, or that iron loading decreases the activity
of the dehydrase molecules. The effect is short lived
(Fig. 2a) despite the fact that the concentration of iron
within the liver continued to increase (Fig. 2b). These
findings provide additional support for the transient
occurrence of an "active" pool of iron (1).
Effect of decreased activity of ALA dehydrase on
hepatic heme synthesis. Because the activity (Vmax)
of ALA dehydrase in most mammalian tissues is 20100 times higher than that of ALA synthase or PBG
deaminase (3, 24), it is often thought that activity of
the dehydrase rarely limits the rate of heme synthesis
(24). We show that a 50-70% decrease in ALA dehydrase has only a small effect on hepatic heme synthesis when measured in vitro (Fig. 3). However, larger
decreases in ALA dehydrase affects heme synthesis
drastically (Fig. 3). Furthermore, the effect of a decrease in dehydrase activity on heme synthesis from
ALA depends on the initial concentration of ALA

(Table III) since this will affect the rate of accumulation of PBG. Therefore, during iron loading, the in
vivo activity of ALA dehydrase can decrease the concentration of PBG sufficiently to decrease the rate of
conversion of ALA to heme. Despite the decrease in
the Vmax of ALA dehydrase, restoration of a normal
rate of heme synthesis remains possible if the rate of
PBG formation is sufficient. This condition may be met
because we found that iron loading led to an increase
of ALA synthase (Fig. 2, ref. 1), and probably to an
increase in the hepatic concentration of ALA.
The effect of decreased activity of ALA dehydrase
on heme synthesis in vivo is further complicated since
ALA and PBG can leak out of hepatocytes, especially
when hepatic production and accumulation are increased. This leakage occurs in human acute porphyrias, in certain experimental porphyrias (3, 5) and in
cultured liver cells (25). Because leakage of ALA evidently occurs at concentrations well below the Km of
ALA dehydrase, this loss of substrate may enhance the
effect of a decrease in ALA dehydrase in decreasing
heme synthesis. Because the Km of the dehydrase is so
much higher than that of PBG deaminase, leakage of
ALA probably affects heme synthesis more than does
leakage of PBG.
Separate actions of iron to decrease ALA dehydrase
and to potentiate drug-mediated induction of ALA
synthase. Our studies with iron-dextran and AIA
show that treatment with iron-dextran potentiates the
induction of ALA synthase produced by AIA as early
as 4 h after treatment (Fig. 4a), before the iron-mediated decrease in activity of ALA dehydrase occurred
(Fig. 4b). In fact, simultaneous treatment with AIA
and iron-dextran virtually abolished the decrease in
activity of ALA dehydrase caused by iron-dextran
alone (Fig. 4b; 18-h time point). The explanation for
this protection is unknown, but may be due to substrate
stabilization due to the increased ALA synthase (Fig.
4). It is not due to a decrease in hepatic iron uptake
in rats treated with both AIA and iron-dextran since
hepatic iron concentrations in such rats are similar to
those in rats given iron-dextran alone (results not
shown). These results demonstrate that the potentiation of induction of ALA-synthase following administration of iron and AIA, is not mediated by a decrease
in ALA-dehydrase.
ACKNOWLEDGMENTS
J. Pomeroy provided able technical assistance, E. L. Smith,
and U. Muller-Eberhard gave helpful comments regarding
the manuscript; and D. Burke patiently typed the manuscript.
This work was supported by medical research funds from
the U. S. Veterans Administration and by a grant from the
National Institutes of Health (CA 25012).

Iron Loading and Hepatic Heme Synthesis

1181

REFERENCES
1. Bonkowsky, H. L., J. F. Healey, P. R. Sinclair, J. F.
Sinclair, and J. S. Pomeroy. 1981. Iron and the liver.
Acute and long-term effects of iron-loading on hepatic
haem metabolism. Biochem. J. 196: 57-64.
2. Ibrahim, N. G., J. C. Nelson, and R. D. Levere. 1981.
Control of 6-aminolaevulinate synthase and haem oxygenase in chronic iron-overloaded rats. Biochem. J. 200:
35-42.
3. Bonkowsky, H. L. 1982. Porphyrin and heme metabolism and the porphyrias. In Hepatology-A Textbook of
Liver Disease. D. Zakim and T. D. Boyer, editors.
W. B. Saunders Company, Philadelphia. 351-398.
4. Elder, G. H. 1980. Haem synthesis and breakdown. In
Iron in Biochemistry and Medicine, II. A. Jacobs and M.
Worwood, editors. Academic Press, Inc., London and
New York. p. 245-292.
5. Tschudy, D. P., and J. M. Lamon. 1980. Porphyrin metabolism and the porphyrias. In Metabolic Disease and
Control. P. K. Bondy and L. E. Rosenberg, editors.
W. B. Saunders Company, Philadelphia. 8th edition. pp.
939-1007.
6. Kushner, J. P., D. P. Steinmuller, and G. R. Lee. 1975.
The role of iron in the pathogenesis of porphyria cutanea
tarda II. Inhibition of uroporphyrinogen decarboxylase.
J. Clin. Invest. 56: 661-667.
7. Woods, J. S., R. Kardish, and B. A. Fowler. 1981. Studies
on the action of porphyrinogenic trace metals on the
activity of hepatic uroporphyrinogen decarboxylase.
Biochem. Biophys. Res. Commun. 103: 264-271.
8. Blekkenhorst, G. H., L. Eales, and N. R. Pimstone. 1979.
Iron and porphyria cutanea tarda: activation of uroporphyrinogen decarboxylase by ferrous iron. S. Afr. Med.
J. 56: 918-920.
9. Bonkowsky, H. L., P. Sinclair, and J. F. Sinclair. 1979.
Hepatic heme metabolism and its control. Yale J. Biol.
Med. 52: 13-37.
10. Healey, J. F., H. L. Bonkowsky, P. R. Sinclair, and
J. F. Sinclair. 1981. Conversion of 5-aminolaevulinate
into haem by liver homogenates. Comparison of rat and
chick embryo. Biochem. J. 198: 595-604.
11. Bonkowsky, H. L., S. J. Carpenter, and J. F. Healey.
1979. Iron and the liver: subcellular distribution of iron
and decreased microsomal cytochrome P450 in livers of
iron-loaded rats. Arch. Pathol. Lab. Med. 103: 21-29.

1182

12. Buege, J. A., and S. D. Aust. 1977. Microsomal lipid
peroxidation. Methods Enzymol. 52: 302-310.
13. Mauzerall, D., and S. Granick. 1956. The occurrence
and determination of S-aminolevulinic acid and porphobilinogen in urine. J. Biol. Chem. 219: 435-446.
14. Elder, G. H., and P. C. Wyvill. 1982. Assay of uroporphyrinogen decarboxylase. Enzyme. 23: 186-193.
15. Ibrahim, N. G., S. T. Hoffstein, and M. L. Freedman.
1979. Induction of liver cell haem oxygenase in ironoverloaded rats. Biochem. J. 180: 257-263.
16. Stein, J. A., D. P. Tschudy, P. L. Corcoran, and A. Collins. 1970. 6-aminolevulinic acid synthetase III. Synergistic effect of chelated iron on induction. J. Biol. Chem.
245: 2213-2218.
17. Maines, M. D. 1979. Role of trace metals in regulation
of cellular heme and hemoprotein metabolism: sensitizing effects of chronic iron treatment on acute gold toxicity. Drug Metab. Rev. 9: 237-255.
18. Shemin, D. 1972. 5-Aminolevulinic acid dehydrase. In
The Enzymes. P. Boyer, editor. Academic Press, Inc.,
New York. 3rd edition. pp. 323-337.
19. Keberle, H. 1964. The biochemistry of desferrioxamine
and its relation to iron metabolism. Ann. NY Acad. Sci.
119: 758-768.
20. Dailey, H. A., Jr., and J. Lascelles. 1977. Reduction of
iron and synthesis of protoheme by Spirillum itersonji
and other organisms. J. Bacteriol. 129: 815-820.
21. Tschudy, D. P., R. A. Hess, and B. C. Frykholm. 1981.
Inhibition of 5-aminolevulinic acid dehydrase by 4,6dioxoheptanoic acid. J. Biol. Chem. 256: 9915-9923.
22. Louw, M., A. C. Neethling, V. A. Percy, M. Carstens,
and B. C. Shanley. 1977. Effects of hexachlorobenzene
feeding and iron overload on enzymes of haem biosynthesis and cytochrome P450 in rat liver. Clin. Sci. Mol.
Med. 53: 111-115.
23. Doyle, D., and R. T. Schimke. 1969. The genetic and
developmental regulation of hepatic 6-aminolevulinate
dehydrase in mice. J. Biol. Chem. 244: 5449-5459.
24. Tait, G. H. 1978. The biosynthesis and degradation of
heme. In Heme and Hemoproteins. F. De Matteis and
W. N. Aldridge, editors. Handbook of Experimental
Pharmacology. Springer Verlag, Berlin. 44: 1-48.
25. Sinclair, P., and S. Granick. 1977. Two methods for determining the activity of 6-aminolevulinate synthase
within intact liver cells in culture. Anal. Biochem. 79:
380-393.

Bonkowsky, Healey, Sinclair, Sinclair, Shedlofsky, and Elder

